A$.$ Based on the calculation in part $1$A$,$ the profit margin dropped dramatically from the year ended January $29,2022,$ to January $28,2023.$ What does the drop imply, and what are the possible reasons for the decline? $(25$ marks$)$ B$.$ Based on the calculation in part $1$B$,$ the current ratio and times interest earned ratios have decreased from the year ended January $29,2022,$ to January $28,2023.$ What does the change imply, and what could be the possible reasons for the change? $(25$ marks$)$ C$.$ Overall, if you are the investor, would you invest in Abercrombie Fitch Co$,$ given the information included in the Annual Report and external sources? Provide justification to support your answers. $(10$ marks$)($Hints: You may find additional information regarding the company$$s operation in item $7$ Management Discussion and Analysis of the annual report. You may also search for additional information from credible news sources and include them in your answer.$)$ Abercrombie & Fitch Co$.$ Consolidated Balance Sheets $($Thousands$.$ excent par value amounts$)$Abercrombie & Fitch Co$.$ Consolidated Statements of Cash Flows $($Thousands$)$ Fiscal $2022$ Fiscal $2021$ I ne accompany$$ng $$votes are an $$ntegra$$ part or tnese consol$$aatea r$$nanc$$a$$ statements.Abercrombie & Fitch Co$.$ Consolidated Statements of Stockholders' Equity $($Thousands$,$ except per share amounts$)$Abercrombie & Fitch Co$.$ Consolidated Statements of Operations and Comprehensive $($Loss$)$ Income $($Thousands$,$ except per share amounts$)$Item $7.$ Management's Discussion and Analysis of Financial Condition and Results of Operations The following Management's Discussion and Analysis of Financial Condition and Results of Operations $("$MD&A$")$ generally discusses our results of operations for Fiscal $2022$ and Fiscal $2021$ and provides comparisons between such fiscal years. For discussion and comparison of Fiscal $2021$ and Fiscal $2020,$ see "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II$,$ Item $7$ of our Annual Report on Form $10-$K for Fiscal $2021,$ filed with the SEC on March $28,2022.$ This MD&A should be read together with the Company's audited Consolidated Financial Statements and notes thereto included in this Annual Report on Form $10-$K in "ITEM $8.$ FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA," to which all references to Notes in MD&A are made. INTRODUCTION MD&A is provided as a supplement to the accompanying Consolidated Financial Statements and notes thereto to help provide an understanding of the Company's results of operations, financial condition, and liquidity. MD&A is organized as follows: $-$ Overview. A general description of the Company's business and certain segment information, and an overview of key performance indicators reviewed by management in assessing the Company's results. $-$ Current Trends and Outlook. A discussion of the Company's long$-$term plans for growth and a summary of the Company's performance over recent years, primarily Fiscal $2022$ and Fiscal $2021.-$ Results of Operations. An analysis of certain components of the Company's Consolidated Statements of Operations and Comprehensive $($Loss$)$ Income for Fiscal $2022$ as compared to Fiscal $2021.-$ Liquidity and Capital Resources. A discussion of the Company's financial condition, changes in financial condition and liquidity as of January $28,2023,$ which includes $($i$)$ an analysis of changes in cash flows for Fiscal $2022$ as compared to Fiscal $2021,($ii$)$ an analysis of liquidity, including availability under the Company's credit facility, and outstanding debt and covenant compliance and $($iii$)$ a summary of contractual and other obligations as of January $28,2023.-$ Recent Accounting Pronouncements. The recent accounting pronouncements the Company has adopted or is currently evaluating, including the dates of adoption or expected dates of adoption, as applicable, and anticipated effects on the Company's audited Consolidated Financial Statements, are included in Note $2$ "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES." $-$ Critical Accounting Estimates. A discussion of the accounting estimates considered to be important to the Company's results of operations and financial condition, which typically require significant judgment and estimation on the part of the Company's management in their application. $-$ Non$-$GAAP Financial Measures. MD&A provides a discussion of certain financial measures that have been determined to not be presented in accordance with accounting principles generally accepted in the U$.$S$.("$GAAP$").$ This section includes certain reconciliations between GAAP and non$-$GAAP financial measures and additional details on non$-$GAAP financial measures, including information as to why the Company believes the non$-$GAAP financial measures provided within MD&A are useful to investors.